Literature DB >> 17298

Immunologic studies and clinical follow-up HBsAg-positive polyarteritis nodosa.

T D Boyer, M J Tong, J Rakela, T B Reynolds.   

Abstract

Three patients with hepatitis B surface antigen (HBsAg)-positive polyarteritis nodosa (PAN) who are clinically well 4 1/2-5 1/2 years after their initial illnesses are described. In each case electron microscopic studies demonstrated the presence of aggregates of HBsAg in both acute and quiescent phase sera. One patient had a lower circulating HBsAg titer during the acute illness, while no change in serial HBsAg titers was observed in the other two patients. Two of the three patients showed lymphocyte transformation to purified HBsAg during the quiescent phase of the PAN. The role of immune complexes in the pathogenesis of HBsAg-positive PAN is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17298     DOI: 10.1007/BF01072501

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  22 in total

1.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

2.  Four cases of periarteritis nodosa associated with persistant Australia antigen.

Authors:  C Trepo; J Thivolet; R Lambert
Journal:  Digestion       Date:  1972       Impact factor: 3.216

3.  Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children.

Authors:  W J Brzosko; K Krawczyński; T Nazarewicz; M Morzycka; A Nowoslawski
Journal:  Lancet       Date:  1974-08-31       Impact factor: 79.321

4.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

5.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

6.  Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa.

Authors:  A M Prince; C Trepo
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

7.  Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers.

Authors:  J O Nielsen; M H Nielsen; P Elling
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

8.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

9.  Lymphocyte stimulation in hepatitis B infections.

Authors:  M J Tong; A M Wallace; R L Peters; T B Reynolds
Journal:  N Engl J Med       Date:  1975-08-14       Impact factor: 91.245

10.  The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa.

Authors:  C G Trepo; A J Zucherman; R C Bird; A M Prince
Journal:  J Clin Pathol       Date:  1974-11       Impact factor: 3.411

View more
  1 in total

1.  Arthritis and hepatitis.

Authors:  R T Mirise; R C Kitridou
Journal:  West J Med       Date:  1979-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.